- Home
- WDC vs TEVA Comparison
WDC vs TEVA Comparison
Compare WDC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDC
- TEVA
- Stock Information
- Founded
- WDC 1970
- TEVA 1901
- Country
- WDC United States
- TEVA Israel
- Employees
- WDC N/A
- TEVA N/A
- Industry
- WDC Electronic Components
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- WDC Technology
- TEVA Health Care
- Exchange
- WDC Nasdaq
- TEVA Nasdaq
- Market Cap
- WDC 26.3B
- TEVA 21.2B
- IPO Year
- WDC N/A
- TEVA N/A
- Fundamental
- Price
- WDC $103.32
- TEVA $18.65
- Analyst Decision
- WDC Buy
- TEVA Strong Buy
- Analyst Count
- WDC 19
- TEVA 7
- Target Price
- WDC $88.47
- TEVA $24.71
- AVG Volume (30 Days)
- WDC 7.7M
- TEVA 10.4M
- Earning Date
- WDC 10-23-2025
- TEVA 11-05-2025
- Dividend Yield
- WDC 0.39%
- TEVA N/A
- EPS Growth
- WDC N/A
- TEVA N/A
- EPS
- WDC 5.14
- TEVA N/A
- Revenue
- WDC $9,520,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- WDC $17.03
- TEVA $4.07
- Revenue Next Year
- WDC $5.14
- TEVA $0.81
- P/E Ratio
- WDC $19.92
- TEVA N/A
- Revenue Growth
- WDC 50.70
- TEVA 2.08
- 52 Week Low
- WDC $28.83
- TEVA $12.47
- 52 Week High
- WDC $103.78
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- WDC 89.55
- TEVA 51.97
- Support Level
- WDC $77.90
- TEVA N/A
- Resistance Level
- WDC $82.32
- TEVA $19.98
- Average True Range (ATR)
- WDC 2.73
- TEVA 0.43
- MACD
- WDC 1.42
- TEVA -0.73
- Stochastic Oscillator
- WDC 96.89
- TEVA 93.23
About WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.